Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-035911

CEO gave up 5,076 shares (to pay taxes)

  • CEO acquired 22,633 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

PIMSTONE SIMON N. · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-24 Exercise or conversion : show line 1 in the form +22,633 $3.76 $85,100 232,819 D
2021-05-24 Shares withheld for taxes : show line 2 in the form −5,076 $19.17 $97,307 227,743 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-05-24 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −22,633 0 D
Loading xslF345X03/doc4.xml…